Why would anyone consider taking Praluent job?

[Anonymous]

He doth protest too much and you made another error - it's choose not chose.

If challenging issues with reimbursement are supposed to be a reason not to launch a blockbuster drug then you are the true douche bag here and it's a good thing you "sell" that easy to "sell" eye drug.

Wow, your re a completed idiot. Talk about people wanting to give you fair warning. You don't dserve any of that. I agree that in about 6 months you will be leaving negative comments on here whining and crying like a baby. You're really sad. Very sad.

 

[Anonymous]

The oral product is at least 2-3 years away. The culture here is toxic and people will be bitching on this sight after Len tells them they are overpaid order takers. He pays order takers accordingly.

Know your place

 

[Anonymous]

why so little respect when Eylea sales have been stellar?

 

[Anonymous]

Sure, that's why this drug is on fire and Zetia is ignored. Get a grip - Amgen and Sanofi/Regeneron are going to kill it on these drugs. Statins barely have 50% compliance - look at the compliance stats on these 2x monthly subQ drugs.

The only reason not to take a job selling these is if you are convinced the company is going to run a shit show. The products are solid - the companies and strategy are the only thing suspect here.

And you think an injectable will have good compliance? Even if the Drs prescribe it, getting the patients to take it is another story, even if insurance covers it.

 

[Anonymous]

The outcomes study is not due to finish until 2017. By then there may be an oral knocking on the door.